Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Efrat Zohar-Dayan"'
Autor:
Ben Pode-Shakked, Ortal Barel, Amihood Singer, Miriam Regev, Hana Poran, Aviva Eliyahu, Yael Finezilber, Meirav Segev, Michal Berkenstadt, Hagith Yonath, Haike Reznik-Wolf, Yael Gazit, Odelia Chorin, Gali Heimer, Lidia V. Gabis, Michal Tzadok, Andreea Nissenkorn, Omer Bar-Yosef, Efrat Zohar-Dayan, Bruria Ben-Zeev, Nofar Mor, Nitzan Kol, Omri Nayshool, Noam Shimshoviz, Ifat Bar-Joseph, Dina Marek-Yagel, Elisheva Javasky, Reviva Einy, Moran Gal, Julia Grinshpun-Cohen, Mordechai Shohat, Dan Dominissini, Annick Raas-Rothschild, Gideon Rechavi, Elon Pras, Lior Greenbaum
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated
Externí odkaz:
https://doaj.org/article/e733bb6318cd4cbcadc0d78a11b7a3cd
Autor:
Livnat Brill, Esther Ganelin-Cohen, Ron Dabby, Shira Rabinowicz, Efrat Zohar-Dayan, Netaniel Rein, Eyal Aloni, Yuval Karmon, Adi Vaknin-Dembinsky
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Introduction: Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD) have been recognized over the past 10 years as distinct inflammatory, demyelinating diseases of the central nervous system (CNS). Antibodies against MOG are
Externí odkaz:
https://doaj.org/article/330033f5252344aeb6bc32a4e5ac672c
Autor:
Michal, Tzadok, Nasrin, Hamed, Gali, Heimer, Efrat, Zohar-Dayan, Shira, Rabinowicz, Bruria, Ben Zeev
Publikováno v:
Pediatric Neurology. 136:15-19
Several retrospective studies on pediatric epilepsy reported positive effects of cannabidiol-enriched artisanal cannabis oil and pure cannabidiol oil on seizure reduction.This is a retrospective study of children and adolescents with refractory epile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02308b67a3b5583ee97a643f3d0b51a9
https://doi.org/10.1016/j.pediatrneurol.2022.06.016
https://doi.org/10.1016/j.pediatrneurol.2022.06.016
Autor:
Sotirios Keros, Jennifer Heim, Wejdan Hakami, Efrat Zohar‐Dayan, Bruria Ben‐Zeev, Zach Grinspan, Michael C. Kruer, Andrea L. Meredith
Publikováno v:
Movement Disorders Clinical Practice. 9:229-235
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13d050465728a437819b6edbff538090
https://doi.org/10.1002/mdc3.13394
https://doi.org/10.1002/mdc3.13394
Autor:
Odelia Chorin, Amihood Singer, Aviva Eliyahu, Mordechai Shohat, Dan Dominissini, Annick Raas-Rothschild, Moran Gal, Gideon Rechavi, Andreea Nissenkorn, Hana Poran, Julia Grinshpun-Cohen, Michal Berkenstadt, Yael Gazit, Lidia V. Gabis, Yael Finezilber, Bruria Ben-Zeev, Noam Shimshoviz, Hagith Yonath, Omri Nayshool, Elon Pras, Nofar Mor, Reviva Einy, Efrat Zohar-Dayan, Miriam Regev, Michal Tzadok, Haike Reznik-Wolf, Ben Pode-Shakked, Elisheva Javasky, Ortal Barel, Lior Greenbaum, Dina Marek-Yagel, Ifat Bar-Joseph, Meirav Segev, Nitzan Kol, Gali Heimer, Omer Bar-Yosef
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Exome sequencing (ES) is an important diagnostic tool for individuals with neurodevelopmental disorders (NDD) and/or multiple congenital anomalies (MCA). However, the cost of ES limits the test's accessibility for many patients. We evaluated the yiel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5f147b62e189389a2194182b3c7132
http://europepmc.org/articles/PMC8476634
http://europepmc.org/articles/PMC8476634
Autor:
Adi Vaknin-Dembinsky, Ron Dabby, Shira Rabinowicz, Netaniel Rein, Eyal Aloni, Efrat Zohar-Dayan, Livnat Brill, Yuval Karmon, Esther Ganelin-Cohen
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Frontiers in Neurology
Frontiers in Neurology
Introduction: Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders (MOGAD) have been recognized over the past 10 years as distinct inflammatory, demyelinating diseases of the central nervous system (CNS). Antibodies against MOG are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d436fd81e5cc8e1239931a9086c34591
https://pubmed.ncbi.nlm.nih.gov/33584514
https://pubmed.ncbi.nlm.nih.gov/33584514